Walleye Capital LLC Olema Pharmaceuticals, Inc. Transaction History

Walleye Capital LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$10.95 - $16.62 $1,949 - $2,958	-178 Reduced 1.47%	11,966 $135,000
Q4 2023 Feb 14, 2024	SELL	$10.53 - $17.14 $1.53 Million - $2.48 Million	-144,885 Reduced 92.27%	12,144 $170,000
Q3 2023 Nov 14, 2023	BUY	$8.19 - $12.98 $1.29 Million - $2.04 Million	157,029 New	157,029 $1.94 Million
Q1 2023 May 15, 2023	BUY	$2.55 - $4.97 $385,141 - $750,648	151,036 Added 482.53%	182,337 $632,000
Q4 2022 Feb 14, 2023	BUY	$2.27 - $3.76 $71,053 - $117,691	31,301 New	31,301 $76,000
Q2 2022 Aug 08, 2022	SELL	$2.04 - $4.61 $145,684 - $329,218	-71,414 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$3.89 - $9.43 $463,334 - $1.12 Million	-119,109 Reduced 62.52%	71,414 $304,000
Q4 2021 Mar 03, 2022	BUY	$8.75 - $30.71 $1.67 Million - $5.85 Million	190,523 New	190,523 $1.78 Million

145

58.3M

141K

23.1K

Ticker OLMA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,419,600
Market Cap $248M
Description
Olema Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies for women's cancers. Its lead product candidate is OP-1250, an estrogen receptor (ER) antagonist and a selective ER degrader, which is in Phase 1/2 clinical trial for the treatment of recurrent, local...

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Capital LLC with notifications on news.